SCHEMBL12002183

SCHEMBL12002183

BN1CCN(CCn2c(=O)cc(C)c3ccc(OC)cc32)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.53
ALDH1A1 P00352 2/20 0.41
CCNE2 O96020 1/20 0.41
CDK4 P11802 1/20 0.41
CCND1 P24385 1/20 0.41
CCNE1 P24864 1/20 0.41
CDK2 P24941 1/20 0.41
KDM4E B2RXH2 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TSHR P16473 3/20 0.41
TP53 P04637 2/20 0.41
HTR7 P34969 2/20 0.41
POLB P06746 1/20 0.41
HPGD P15428 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CNR1 P21554 1/20 0.41
CNR2 P34972 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11968773 0.87 KCNH2 (0.56) KCNH2ALDH1A1CCNE2CDK4CCND1
SCHEMBL2799380 0.86 KCNH2 (0.53) KCNH2ALDH1A1CCNE2CDK4CCND1
SCHEMBL4782432 0.84 KCNH2 (0.58) KCNH2ALDH1A1CCNE2CDK4CCND1
SCHEMBL12002102 0.84 KCNH2 (0.62) KCNH2TSHRTP53POLBHPGD
SCHEMBL13264429 0.81 KCNH2 (0.42) KCNH2ALDH1A1KDM4EMAPK1HTT
SCHEMBL2795878 0.81 KCNH2 (0.47) KCNH2ALDH1A1HTTTSHRTP53
SCHEMBL12002088 0.80 KCNH2 (0.41) KCNH2ALDH1A1CCNE2CDK4CCND1
SCHEMBL12002174 0.80 KCNH2 (0.41) KCNH2ALDH1A1CCNE2CDK4CCND1
SCHEMBL11968772 0.80 KCNH2 (0.61) KCNH2ALDH1A1KDM4EPOLBCNR1
SCHEMBL2797974 0.79 CCNE2 (0.47) KCNH2ALDH1A1CCNE2CDK4CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120214990-A1 QUINOLINONES AND QUINOXALINONES AS ANTIBACTERIAL COMPOSITION TAISHO PHARMACEUTICAL CO., LTD. (JP) 2012-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120214990-A1 QUINOLINONES AND QUINOXALINONES AS ANTIBACTERIAL COMPOSITION NQO2, ASNS, NDUFS1 KCNH2 525/4885ALDH1A1 3142/4885CCNE2 2264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.